← Leaderboards
Charles David Pauza
Northwestern University
$11,027,875
Attributed
$12,147,368
Total exposure
25
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–15$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$12,147,368 · 25
By mechanism
R01$9,824,417 · 7
R21$1,442,129 · 5
P51$557,572 · 11
P30$173,250 · 1
R03$150,000 · 1
Top collaborators
- Xiaoping Zhu3 shared
Most similar at Northwestern University
Same institution · by research overlap
- David J Klumpp$10,341,734
- Anthony J Schaeffer$7,540,605
- Patricia G Spear$7,695,741
- Syamal K Datta$7,639,482
Others in their field
Top investigators on “Virus”
- David Heimbrook · Leidos Biomedical Research, Inc.$512,873,478
- Lawrence Corey · Fred Hutchinson Cancer Center$392,679,667
- Barton F Haynes · Duke University$328,711,626
- Dennis R. Burton · Scripps Research Institute$276,624,892
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$274,342,142
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
Research focus
VirusHiv InfectionsVaccinesT-LymphocyteAntigensCellsVirus DiseasesMacaca MulattaAidsClinical ResearchReceptorImmunityCommunicable DiseasesMediatingBacteriaB-LymphocytesImmuneDesignAnimal TissuePreventLymphocyteCytokineResponseMacaca
Grant awards (51)
HIV Persistence and Cardiopulmonary Disease$192,500
R21 · FY2015 · HL · contact PI
FcRn-targeted mucosal HIV vaccine$746,981
R01 · FY2014 · AI · contact PI
FcRn-targeted mucosal HIV vaccine$716,450
R01 · FY2013 · AI · contact PI
T-follicular helper cells in Env-immunized macaques$180,363
R21 · FY2013 · AI · contact PI
Synthetic Variable Domain Glycopeptides for Neutralizing Epitope Characterization$180,363
R21 · FY2013 · AI · contact PI
FcRn-targeted mucosal HIV vaccine$775,556
R01 · FY2012 · AI · contact PI
Mechanisms for depleting tumor immunity in AIDS$301,913
R01 · FY2012 · CA · contact PI
T-follicular helper cells in Env-immunized macaques$230,250
R21 · FY2012 · AI · contact PI
Mechanisms for depleting tumor immunity in AIDS$498,338
R01 · FY2011 · CA · contact PI
Mechanisms for depleting tumor immunity in AIDS$308,138
R01 · FY2010 · CA · contact PI
Mechanisms for depleting tumor immunity in AIDS$202,500
R01 · FY2010 · CA · contact PI
Mechanisms for SIV evasion of vaccine immunity: Role of FasL-mediated cell death$580,972
R01 · FY2009 · AI · contact PI
Mechanisms for depleting tumor immunity in AIDS$308,138
R01 · FY2009 · CA · contact PI
Racial Disparity in gamma/delta T cells$75,000
R03 · FY2009 · AI · contact PI
Mechanisms for SIV evasion of vaccine immunity: Role of FasL-mediated cell death$513,083
R01 · FY2008 · AI · contact PI
Gamma/Delta T Cells Surveillance of B Lymphoma in AIDS$224,720
R01 · FY2008 · CA · contact PI
Vaccinia Inhibition of gd T cells is a Immune Evasion Mechanism$172,525
R21 · FY2008 · AI · contact PI
Racial Disparity in gamma/delta T cells$75,000
R03 · FY2008 · AI · contact PI
Mechanisms for SIV evasion of vaccine immunity: Role of FasL-mediated cell death$430,779
R01 · FY2007 · AI · contact PI
Vaccinia Inhibition of gd T cells is a Immune Evasion Mechanism$226,253
R21 · FY2007 · AI · contact PI
Gamma/Delta T Cells Surveillance of B Lymphoma in AIDS$224,720
R01 · FY2007 · CA · contact PI
Mechanisms for SIV evasion of vaccine immunity: Role of FasL-mediated cell death$78,950
R01 · FY2007 · AI · contact PI
Mechanisms for SIV evasion of vaccine immunity: Role of FasL-mediated cell death$1
R01 · FY2007 · AI · contact PI
Mechanisms for SIV evasion of vaccine immunity: Role of FasL-mediated cell death$429,101
R01 · FY2006 · AI · contact PI
Gamma/Delta T Cells Surveillance of B Lymphoma in AIDS$229,116
R01 · FY2006 · CA · contact PI
Gamma/Delta T Cells Surveillance of B Lymphoma in AIDS$100,000
R01 · FY2006 · CA · contact PI
Gamma Delta T Cells and Innate Immunity in AIDS$334,125
R01 · FY2005 · AI
Gamma/Delta T Cells Surveillance of B Lymphoma in AIDS$234,630
R01 · FY2005 · CA
Gamma Delta T Cells and Innate Immunity in AIDS$334,125
R01 · FY2004 · AI
Homologous Tat Vaccine Against SHIV in Macaques$371,250
R01 · FY2003 · AI
Gamma Delta T Cells and Innate Immunity in AIDS$334,125
R01 · FY2003 · AI
Homologous Tat Vaccine Against SHIV in Macaques$352,688
R01 · FY2002 · AI
Gamma Delta T Cells and Innate Immunity in AIDS$259,875
R21 · FY2002 · AI
CORE--NONHUMAN PRIMATE MODELS$0
P30 · FY2002 · CA
IMPROVE PROTECTIVE RESPONSES TO ATTENUATED SHIV VACCINE$423,789
R01 · FY2001 · AI
Homologous Tat Vaccine Against SHIV in Macaques$371,250
R01 · FY2001 · AI
CORE--NONHUMAN PRIMATE MODELS$0
P30 · FY2001 · CA
MECHANISMS FOR CNS DAMAGE &ENCEPHALITIS IN PERSISTENT SIV INFECTION OF MACAQUES$0
P51 · FY2001 · RR
APPLICATION OF POSITRON EMISSION TOMOGRAPHY IMAGING TO AIDS$0
P51 · FY2001 · RR
MONOCYTOTROPISM IN HIV &SIV PATHOGENICITY VIRUS TRANSMISSION COLLAB SUBCONTRACT$0
P51 · FY2001 · RR
EFFECTS OF INFECTION OR VACCINATION ON INTRAEPITHELIAL LYMPHOCYTE POPULATIONS$0
P51 · FY2001 · RR
STRUCTURE &FUNCTION OF RHESUS LYMPHOTACTIN$0
P51 · FY2001 · RR
PERTUSSIS TOXIN TOOL TO STUDY LYMPHOCYTES &NOVEL THERAPY STRATEGY: SIV MACAQUES$0
P51 · FY2001 · RR
MUCOSAL IMMUNITY TO SIV IN RHESUS MACAQUES$0
P51 · FY2001 · RR
IMPROVE PROTECTIVE RESPONSES TO ATTENUATED SHIV VACCINE$373,357
R01 · FY2000 · AI
CORE--NONHUMAN PRIMATE MODELS$173,250
P30 · FY2000 · CA
CNS DAMAGE &ENCEPHALITIS DURING PERSISTENT SIV INFECTION OF MACAQUES$139,393
P51 · FY2000 · RR
MECHANISMS OF ACUTE RETROVIRAL DISEASE IN MACAQUES: SIV$139,393
P51 · FY2000 · RR
EFFECTS OF INFECTION OR VACCINATION ON INTRAEPITHELIAL LYMPHOCYTES: AIDS$139,393
P51 · FY2000 · RR
PERTUSSIS TOXIN TOOL TO STUDY LYMPHOCYTES &NOVEL THERAPY STRATEGY: SIV MACAQUE$139,393
P51 · FY2000 · RR
IMPROVE PROTECTIVE RESPONSES TO ATTENUATED SHIV VACCINE$25,622
R01 · FY2000 · AI